Quarterly report pursuant to Section 13 or 15(d)

Other current assets

v3.20.2
Other current assets
9 Months Ended
Sep. 30, 2020
Other current assets  
Other current assets

Note 7 — Other current assets

Other current assets consisted of the following (in thousands):

September 30, 

December 31, 

    

2020

    

2019

Corporate tax receivable

 

$

13,921

 

$

19,284

Prepayments

 

7,754

 

8,395

Clinical materials

 

2,488

 

1,459

Other current assets

 

2,662

 

1,809

$

26,825

$

30,947